We are live on ! Find out more
HCA

Harbor Capital Advisors Portfolio holdings

AUM $1.47B
1-Year Est. Return 42.58%
This Fund
S&P 500
This Quarter Est. Return
-26.69%
1 Year Est. Return
+42.58%
3 Year Est. Return
+118.91%
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
-$80.7M
Cap. Flow
-$21.4M
Cap. Flow %
-16.31%
Top 10 Hldgs %
31.3%
Holding
169
New
9
Increased
78
Reduced
72
Closed
9

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$3.74M
2
NET icon
Cloudflare
NET
+$1.86M
3
MELI icon
Mercado Libre
MELI
+$1.64M
4
AVLR
Avalara, Inc.
AVLR
+$1.38M
5
WOLF icon
Wolfspeed
WOLF
+$1.36M

Sector Composition

Rank Sector Weight
1 Technology 50.67%
2 Healthcare 20.24%
3 Consumer Discretionary 14.97%
4 Communication Services 9.75%
5 Financials 1.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
51
Thermo Fisher Scientific
TMO
$224B
$798K 0.61%
1,469
-38
-3% -$20.9K
TWTR
52
DELISTED
Twitter, Inc.
TWTR
$784K 0.6%
20,980
-44,162
-68% -$1.89M
COO icon
53
Cooper Companies
COO
$15B
$768K 0.58%
9,812
-204
-2% -$18.1K
SMAR
54
DELISTED
Smartsheet Inc.
SMAR
$761K 0.58%
+24,228
New +$1M
AMED
55
DELISTED
Amedisys
AMED
$757K 0.58%
7,205
-236
-3% -$30.2K
BIO icon
56
Bio-Rad Laboratories Class A
BIO
$9.53B
$755K 0.57%
1,525
-34
-2% -$17.7K
RGNX icon
57
Regenxbio
RGNX
$704M
$747K 0.57%
30,251
-2,209
-7% -$55.2K
DXCM icon
58
DexCom
DXCM
$33.8B
$746K 0.57%
10,008
-316
-3% -$28.8K
IDXX icon
59
Idexx Laboratories
IDXX
$46.2B
$737K 0.56%
2,102
-55
-3% -$22.4K
ZM icon
60
Zoom
ZM
$31.1B
$686K 0.52%
6,349
-8,618
-58% -$909K
ARWR icon
61
Arrowhead Research
ARWR
$12.6B
$683K 0.52%
19,399
-1,203
-6% -$45.3K
RNAM
62
DELISTED
Avidity Biosciences
RNAM
$682K 0.52%
46,942
+1,503
+3% +$22.4K
MTD icon
63
Mettler-Toledo International
MTD
$28.8B
$661K 0.5%
575
+7
+1% +$8.79K
DDOG icon
64
Datadog
DDOG
$88.6B
$625K 0.48%
+6,564
New +$721K
BPMC
65
DELISTED
Blueprint Medicines
BPMC
$623K 0.47%
12,335
-153
-1% -$8.96K
ARVN icon
66
Arvinas
ARVN
$587M
$616K 0.47%
14,645
-1,844
-11% -$92.5K
NEE icon
67
NextEra Energy
NEE
$179B
$570K 0.43%
7,356
-162
-2% -$12.3K
REPL icon
68
Replimune Group
REPL
$1.15B
$537K 0.41%
30,695
+513
+2% +$8.43K
AUTL
69
Autolus Therapeutics
AUTL
$620M
$467K 0.36%
164,906
+1,763
+1% +$5.37K
QURE icon
70
uniQure
QURE
$3.12B
$442K 0.34%
23,730
-3,658
-13% -$58.2K
PTON icon
71
Peloton Interactive
PTON
$2.45B
$440K 0.33%
47,885
-68,146
-59% -$1.09M
IOVA icon
72
Iovance Biotherapeutics
IOVA
$2.94B
$435K 0.33%
39,434
-2,749
-7% -$36K
SYBX
73
DELISTED
Synlogic
SYBX
$407K 0.31%
23,584
-83
-0.4% -$1.8K
AKUS
74
DELISTED
Akouos Inc
AKUS
$379K 0.29%
80,754
+2,939
+4% +$10.4K
HZNP
75
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$363K 0.28%
+4,553
New +$431K

Similar funds

Harbor Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Harbor Capital Advisors held 169 positions worth $131M, down 38% from $212M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Harbor Capital Advisors withdrew a net $21.4M in Q2 2022, closing 9 positions and reducing 72 holdings. Its most notable exit was SailPoint Technologies Holdings, Inc. Common Stock, an estimated $3.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Harbor Capital Advisors opened a new position in Wolfspeed worth $1.04M.

  • Harbor Capital Advisors's largest Q2 2022 buy was Wolfspeed: 16,341 shares worth $1.04M.
  • Harbor Capital Advisors added most to Okta in Q2 2022, an estimated $3.74M increase.
  • Harbor Capital Advisors's biggest Q2 2022 reduction was Amazon, cutting an estimated $4.21M.
  • Harbor Capital Advisors fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q2 2022, selling an estimated $3.73M.
  • Harbor Capital Advisors's ten largest holdings make up 31% of its $131M portfolio in Q2 2022.
  • Harbor Capital Advisors opened 9 new positions and closed 9 in Q2 2022.
  • Harbor Capital Advisors's portfolio value fell 38% quarter-over-quarter to $131M.

Based on Harbor Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.